Notice Title

Consent to the Distribution of New Medicines

Publication Date
3 Oct 2024

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2024-go4992
Title
View PDF
File Type and Size
PDF (33 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Constella
Active Ingredient: Linaclotide 0.072mg
Dosage Form: Capsule
New Zealand Sponsor: AbbVie Limited
Manufacturer: Forest Laboratories Ireland Limited, Dublin, Ireland
   
Product: Constella
Active Ingredient: Linaclotide 0.145mg
Dosage Form: Capsule
New Zealand Sponsor: AbbVie Limited
Manufacturer: Forest Laboratories Ireland Limited, Dublin, Ireland
   
Product: Constella
Active Ingredient: Linaclotide 0.29mg
Dosage Form: Capsule
New Zealand Sponsor: AbbVie Limited
Manufacturer: Forest Laboratories Ireland Limited, Dublin, Ireland


Dated this 27th day of September 2024.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).